DAA2233 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
59.5% Decrease Gene Expression Level |
|
DAA2234 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
57.8% Decrease Gene Expression Level |
|
DAA2219 |
toll interacting protein decreases with age |
Molecular |
parietal lobe |
Human |
TOLLIP |
53.6% Decrease Gene Expression Level |
|
DAA2218 |
toll interacting protein decreases with age |
Molecular |
parietal lobe |
Human |
TOLLIP |
61.5% Decrease Gene Expression Level |
|
DAA2235 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
36.3% Decrease Gene Expression Level |
|
DAA2257 |
Thioredoxin interacting protein increases with age |
Molecular |
parietal lobe |
Human |
TXNIP |
124.8% Increase Gene Expression Level |
|
DAA2245 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
277.8% Increase Gene Expression Level |
|
DAA2256 |
Thioredoxin interacting protein increases with age |
Molecular |
parietal lobe |
Human |
TXNIP |
143.1% Increase Gene Expression Level |
|
DAA2266 |
Thioredoxin interacting protein increases with age |
Molecular |
temporal lobe |
Human |
TXNIP |
146.6% Increase Gene Expression Level |
|
DAA2267 |
Thioredoxin interacting protein increases with age |
Molecular |
temporal lobe |
Human |
TXNIP |
130.7% Increase Gene Expression Level |
|
DAA2246 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
250.2% Increase Gene Expression Level |
|
DAA718 |
Synaptic density slightly decreases at advanced ages |
Physiological |
frontal lobe |
Human |
— |
— |
|
DAA1098 |
Schlafen Family Member 11 |
Molecular |
frontal lobe |
Human |
SLFN11 |
Increase DNA Methylation |
|
DAA1100 |
Schlafen Family Member 11 |
Molecular |
temporal lobe |
Human |
SLFN11 |
Increase DNA Methylation |
|
DAA2244 |
S100 calcium binding protein A9 increases with age |
Molecular |
frontal lobe |
Human |
S100A9 |
92.8% Increase Gene Expression Level |
|
DAA2232 |
S100 calcium binding protein A9 increases with age |
Molecular |
parietal lobe |
Human |
S100A9 |
229.0% Increase Gene Expression Level |
|
DAA2231 |
S100 calcium binding protein A8 increases with age |
Molecular |
parietal lobe |
Human |
S100A8 |
1228.2% Increase Gene Expression Level |
|
DAA2217 |
S100 calcium binding protein A8 increases with age |
Molecular |
hippocampus |
Human |
S100A8 |
1115.4% Increase Gene Expression Level |
|
DAA2243 |
S100 calcium binding protein A8 increases with age |
Molecular |
frontal lobe |
Human |
S100A8 |
921.4% Increase Gene Expression Level |
|
DAA2206 |
S100 calcium binding protein A8 increases with age |
Molecular |
temporal lobe |
Human |
S100A8 |
530.6% Increase Gene Expression Level |
|
DAA1088 |
Rhomboid Domain Containing 1 |
Molecular |
temporal lobe |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1086 |
Rhomboid Domain Containing 1 |
Molecular |
frontal lobe |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1222 |
RELN promoter methylation increase |
Molecular |
brain, cerebral cortex |
Human |
RELN |
— |
|
DAA1096 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
temporal lobe |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1094 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
frontal lobe |
Human |
PTGER3 |
Increase DNA Methylation |
|